Similar articles

• Perinatal factors in patent ductus arteriosus in very low-birthweight infants.

  Chen YY, Wang HP, Chang JT, Chiou YH, Huang YF, Hsieh KS; Taiwan Premature Infant Development Collaborative Study Group. Chen YY, et al. Pediatr Int. 2014 Feb;56(1):72-6. doi: 10.1111/ped.12199. Pediatr Int. 2014. PMID: 23937654
• Patent ductus arteriosus, prematurity, and respiratory distress syndrome.

  Sissman NJ. Sissman NJ. JAMA. 1989 Jun 16;261(23):3410. JAMA. 1989. PMID: 2724482 No abstract available.
• Effect of persistent patent ductus arteriosus on mortality and morbidity in very low-birthweight infants.

  Tauzin L, Joubert C, Noel AC, Bouissou A, Moulies ME. Tauzin L, et al. Acta Paediatr. 2012 Apr;101(4):419-23. doi: 10.1111/j.1651-2227.2011.02550.x. Epub 2012 Jan 9. Acta Paediatr. 2012. PMID: 22133090
• Management and outcomes of very low birth weight.

  Eichenwald EC, Stark AR. Eichenwald EC, et al. N Engl J Med. 2008 Apr 17;358(16):1700-11. doi: 10.1056/NEJMra0707601. N Engl J Med. 2008. PMID: 18420502 Review. No abstract available.
• Paracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm neonates: a meta-analysis of randomized controlled trials.

  Huang X, Wang F, Wang K. Huang X, et al. J Matern Fetal Neonatal Med. 2018 Aug;31(16):2216-2222. doi: 10.1080/14767058.2017.1338263. Epub 2017 Jul 18. J Matern Fetal Neonatal Med. 2018. PMID: 28720053 Review.